Scarica l'app Stockscreener
32.64
0.03%
0.010
Dopo l'orario di chiusura:
32.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$32.63
Aprire:
$32.59
Volume 24 ore:
2.38M
Relative Volume:
0.56
Capitalizzazione di mercato:
$13.75B
Reddito:
$2.26B
Utile/perdita netta:
$1.09B
Rapporto P/E:
13.93
EPS:
2.3431
Flusso di cassa netto:
$2.70B
1 W Prestazione:
+1.02%
1M Prestazione:
-0.21%
6M Prestazione:
+22.43%
1 anno Prestazione:
+23.68%
Intervallo 1D:
$32.42
$32.77
Intervallo di 1 settimana:
$32.15
$32.82
Portata 52W:
$24.05
$34.31
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.64 | 13.61B | 2.26B | 1.09B | 2.70B | 2.3431 |
|
ONC
Beone Medicines Ltd Adr
|
246.68 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.09 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
77.49 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Squarepoint Ops LLC Lowers Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Janus Henderson Group PLC Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
University of Texas Texas AM Investment Management Co. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
USS Investment Management Ltd Has $4.14 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Tidal Investments LLC Sells 9,371 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Worldquant Millennium Advisors LLC Has $15.57 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
State of Wyoming Has $385,000 Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Captrust Financial Advisors Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Two Sigma Investments LP Has $61.74 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Nuveen Asset Management LLC Buys 8,802 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
How to Take Advantage of moves in (RPRX) - news.stocktradersdaily.com
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Quantinno Capital Management LP - MarketBeat
Raiffeisen Bank International AG Makes New $506,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Two Sigma Advisers LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma - insights.citeline.com
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Man Group plc - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Ethic Inc. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Holdings Trimmed by OMERS ADMINISTRATION Corp - MarketBeat
Royalty Pharma at RBC Capital Markets: Strategic Funding Insights By Investing.com - Investing.com Nigeria
Transcript : Royalty Pharma plc Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 04 - marketscreener.com
Occudo Quantitative Strategies LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
RPRX Stock Performance Following Recent Offering Details | RPRX Stock News - GuruFocus
Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - Defense World
Royalty Pharma plc (NASDAQ:RPRX) Receives $42.50 Consensus PT from Analysts - Defense World
Patient Capital Management LLC Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma completes major acquisition By Investing.com - Investing.com Canada
Royalty Pharma completes major acquisition - Investing.com
Balyasny Asset Management L.P. Purchases Shares of 59,755 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Bank of America Corp DE - MarketBeat
Royalty Pharma Completes RP Management Acquisition - citybiz
Baird Financial Group Inc. Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Deutsche Bank AG Buys 847,704 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Morgan Stanley Initiates Coverage on Royalty Pharma (NASDAQ:RPRX) - Defense World
Royalty Pharma (NASDAQ:RPRX) Stock Rating Upgraded by StockNews.com - MarketBeat
Royalty Pharma Closes Acquisition of External Manager - marketscreener.com
Royalty Pharma plc Completes Internalization of Management Structure with Overwhelming Shareholder Support - Nasdaq
Royalty Pharma Completes the Acquisition of Its External Manager - The Manila Times
Royalty Pharma Completes The Acquisition Of Its External Manager - marketscreener.com
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):